Santen Pharmaceutical Co., Ltd.

30 clinical trials · Sponsor

Record	Firm	Date
A Pharmacokinetics (PK) Study in Healthy Adults (NCT06911216)	Santen Pharmaceutical Co., Ltd.	2025-03-17
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China (NCT06666855)	Santen Pharmaceutical Co., Ltd.	2024-11-28
A Study in Chinese Patients With Acquired Blepharoptosis (NCT06683651)	Santen Pharmaceutical Co., Ltd.	2024-10-22
Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers (NCT05905653)	Santen Pharmaceutical Co., Ltd.	2023-05-25
A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT05495061)	Santen Pharmaceutical Co., Ltd.	2022-08-09
A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension (NCT05503901)	Santen Pharmaceutical Co., Ltd.	2022-08-08
A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension (NCT03822559)	Santen Pharmaceutical Co., Ltd.	2019-01-20
A Study Assessing the Efficacy and Safety of DE-127 Ophthalmic Solution in Subjects With Mild or Moderate Myopia (APPLE) (NCT03329638)	Santen Pharmaceutical Co., Ltd.	2017-10-27
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease (NCT03216096)	Santen Pharmaceutical Co., Ltd.	2017-09-08

Every clearance here is in the API, with alerts when new ones post.